Klaus Stöckemann

ZONARE Medical Systems, Inc. designs, develops and manufactures ultrasound solutions. The firm offers ultrasound systems; curved array, curved-phased array, linear array, phased array, endocavity, and continuous wave transducers; accessories, such as transducer biopsy guides and user interface sterile covers; and upgrades, including imaging, workflow, and clinical enhancements. The company was founded by Mir A. Imran and Glen W. McLaughlin in 1999 and is headquartered in Mountain View, CA.

IntelliDx, Inc. develops medical devices. It offers automated ex vivo blood analysis systems that measure the constituents of flowing human blood, and automated blood glucose monitoring systems that measure glucose in hospitalized patients who have abnormally elevated sugar levels. The company was founded in 2000 and is headquartered in Santa Clara, CA.

3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors.

Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Hematris Wound Care GmbH develops, manufactures and markets products in the field of hemostasis. Its brand Hematrix is a wound patch which is used for arterial injury-related bleeding and external bleeding caused by surgical intervention. The company was founded in 2006 by Stefan Bertsch and Hans-Georg Langer and is headquartered in Neubiberg, Germany.

Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany.